Adamas Pharmaceuticals Inc
ADMS·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$5.06
Today
+0.0%
YTD
+0.0%
About
Adamas Pharmaceuticals is a healthcare company founded in 2000. The firm is based in Emeryville, California, and serves clients across the US. Listed on the NASDAQ CM with the ticker ADMS, Adamas focuses on developing therapies for patients suffering from chronic neurologic disorders. Track ADMS price updates via your eToro watchlist.
Price chart
Closing price history for ADMS (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-4.85
P/S (TTM)Unknown
P/B (TTM)-17.38
Market cap$376.37M
Cap tierSmall-cap
Industry avg P/E-43.26
Profitability
Gross margin97.64%
EBIT margin-44.56%
Net margin-75.37%
ROE-851.33%
ROA-45.31%
Earnings & Revenue
Revenue (TTM)$88.19M
Revenue growth (1Y)+26.3%
EPS (TTM)-$1.70
Free cash flow$-41.81M
Total debt$134.14M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.03
Employees138
Next earnings23 Feb '22
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.